{"id":9,"date":"2013-02-01T10:48:37","date_gmt":"2013-02-01T15:48:37","guid":{"rendered":"http:\/\/licensinglaw.net\/blog3\/?page_id=9"},"modified":"2021-04-12T10:11:59","modified_gmt":"2021-04-12T14:11:59","slug":"prosecution","status":"publish","type":"page","link":"https:\/\/licensinglaw.net\/blog3\/?page_id=9","title":{"rendered":"Prosecution"},"content":{"rendered":"<p style=\"text-align: justify;\">Having a difficult time convincing the Patent Office to grant your patent?\u00a0 Perhaps we can help.\u00a0 Our fresh set of eyes have quickly resolved long-standing prosecution delays on innovations as diverse as finished dosage formulations, new labeling indications, combination products and biological products.<\/p>\n<p><a href=\"http:\/\/licensinglaw.net\/blog3\/wp-content\/uploads\/2013\/02\/rhGH_plasmid.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-239 size-thumbnail\" src=\"https:\/\/licensinglaw.net\/blog3\/wp-content\/uploads\/2013\/02\/rhGH_plasmid-150x150.jpg\" alt=\"Increase rhGH expression with an optimized expression plasmid\" width=\"150\" height=\"150\" srcset=\"https:\/\/licensinglaw.net\/blog3\/wp-content\/uploads\/2013\/02\/rhGH_plasmid-150x150.jpg 150w, https:\/\/licensinglaw.net\/blog3\/wp-content\/uploads\/2013\/02\/rhGH_plasmid-432x432.jpg 432w, https:\/\/licensinglaw.net\/blog3\/wp-content\/uploads\/2013\/02\/rhGH_plasmid-268x268.jpg 268w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/a><\/p>\n<p style=\"text-align: justify;\">Having a difficult time with a competitor&#8217;s earlier-filed, conflicting application?\u00a0 We may be able to help with this, too; our clients have found that our careful workmanship may compensate for months &#8211; or even years &#8211; of filing date handicap.\u00a0 Because this both gets a patent and prevents a competitor from getting a blocking patent, we call this &#8220;<a href=\"https:\/\/licensinglaw.net\/blog3\/?page_id=212\">F2O Prosecution<\/a>.&#8221;<\/p>\n<p style=\"text-align: justify;\"><a href=\"http:\/\/licensinglaw.net\/blog3\/wp-content\/uploads\/2013\/02\/interferon_efficacy.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-241 size-thumbnail\" src=\"https:\/\/licensinglaw.net\/blog3\/wp-content\/uploads\/2013\/02\/interferon_efficacy-150x150.jpg\" alt=\"\" width=\"150\" height=\"150\" srcset=\"https:\/\/licensinglaw.net\/blog3\/wp-content\/uploads\/2013\/02\/interferon_efficacy-150x150.jpg 150w, https:\/\/licensinglaw.net\/blog3\/wp-content\/uploads\/2013\/02\/interferon_efficacy-432x432.jpg 432w, https:\/\/licensinglaw.net\/blog3\/wp-content\/uploads\/2013\/02\/interferon_efficacy-268x268.jpg 268w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/a>While we limit our practice to healthcare, within that industry we cover technologies as diverse as gene therapy, insurance reimbursement software, diagnostic algorithms, biotech, small-molecule manufacturing and devices.\u00a0 To learn more, glance through our <a href=\"https:\/\/licensinglaw.net\/blog3\/?page_id=763\">portfolio of sample patents<\/a> in various technologies, and our <a href=\"https:\/\/licensinglaw.net\/blog3\/?page_id=757\">portfolio of sample trademarks<\/a> for various products.<\/p>\n<p style=\"text-align: justify;\">To find out how we can help you, <a href=\"https:\/\/licensinglaw.net\/blog3\/?page_id=22\">Contact Us<\/a>.<\/p>\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Having a difficult time convincing the Patent Office to grant your patent?\u00a0 Perhaps we can help.\u00a0 Our fresh set of eyes have quickly resolved long-standing prosecution delays on innovations as diverse as finished dosage formulations, new labeling indications, combination products and biological products. Having a difficult time with a competitor&#8217;s &#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"template-full-width.php","meta":{"footnotes":""},"class_list":["post-9","page","type-page","status-publish","hentry","column","twocol"],"_links":{"self":[{"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=\/wp\/v2\/pages\/9","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9"}],"version-history":[{"count":36,"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=\/wp\/v2\/pages\/9\/revisions"}],"predecessor-version":[{"id":848,"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=\/wp\/v2\/pages\/9\/revisions\/848"}],"wp:attachment":[{"href":"https:\/\/licensinglaw.net\/blog3\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}